23rd Annual International Workshop on Co-morbidities and Adverse Drug Reactions in HIV

随着抗逆转录病毒疗法（ART）的成功，合并症现在是主要原因 地球仪各地艾滋病毒感染者死亡和残疾的比例，包括低收入和中等收入 （LMIC）。大型会议，如逆转录病毒和免疫学会议， 感染和国际艾滋病协会会议，是科学的重要场所， 关于艾滋病毒科摩罗研究的最新进展的交流，但更小，更亲密 强调讨论和网络的形式对艾滋病毒的职业发展至关重要 科摩罗调查员。共病和药物不良反应国际研讨会 艾滋病毒的反应，现在已经是第23个年头，为<200名代表提供了机会 在一个房间里一起讨论艾滋病研究的最新发现和争议， 两天的格式。全体会议的发言者要么是来自艾滋病毒研究或艾滋病毒领域以外的著名专家 研究人员在一个特定的共同体的专业知识。摘要介绍，包括24 15- 一分钟的谈话和海报会议提供了充足的机会，研究人员提出，并得到 对他们最新工作的反馈。通过此R13，我们建议加强第23次研讨会（10月 25/26日在伦敦举行），目的如下：1）为最新的艾滋病毒科摩罗人提供一个论坛， 通过向LMIC调查人员提供旅行奖学金，支持LMIC的研究， LMIC国际公认的非传染性疾病专家作为全体会议发言人， 并与国际培训计划联络，2）支持早期调查人员， 奖学金计划和职业发展工作室，并指导海报之旅，3）增加 通过全体会议和摘要发言的网播宣传讲习班的影响。通过 为越来越多的科摩罗艾滋病毒调查人员提供“科学之家”， 在世界各地，我们希望促进未来在艾滋病毒合并症方面的研究工作， 将研究结果转化为临床策略，可以提高寿命， PLWH的健康寿命。

With the success of antiretroviral therapy (ART), comorbid diseases are now the leading causes of death and disability in people living with HIV around the globe, including low and middle income countries (LMIC). Large meetings, such as the Conference for Retroviruses and Opportunistic Infections and the International AIDS Society Conference, are important venues for scientific exchange regarding the latest advances in HIV Comorbidity research, but smaller, more intimate formats,that emphasize discussion and networking are critical to the career development of HIV Comorbidity investigators. The International Workshop for Comorbidities and Adverse Drug Reactions in HIV, now in its 23rd year, provides <200 delegates with an opportunity to come together to discuss the latest findings and controversies in HIV Comorbidity research in one-room, two-day format. Plenary speakers are either noted experts from outside of HIV research or HIV researchers with expertise in a specific comorbidity. Abstract presentations including 24 15- minute talks and a poster session provide ample opportunity for researchers to present and get feedback on their latest work. With this R13, we propose to enhance the 23rd Workshop (October 25th/26th in London) with the following aims: 1) to provide a forum for the latest HIV Comorbidity research in LMIC by offering travel scholarships to LMIC investigators, supporting an internationally-recognized expert in non-communicable diseases in LMIC as a plenary speaker, and liaising with international training programs, 2) to support early-stage investigators with a scholarship program and a Career Development Studio, and guided poster tour, 3) to increase the impact of the Workshop through the webcast of plenary and abstract presentations. By providing a “scientific home” to an increasing number of HIV Comorbidity investigators from around the world, we hope to catalyze future research efforts in HIV Comorbidities and facilitate the translation of research findings into clinical strategies that can improve the lifespan and healthspan of PLWH.